Mexico City is served by Mexico City International Airport (IATA Airport Code: MEX). This airport is Latin America's second busiest and one of the largests in traffic, with daily flights to United States and Canada, mainland Mexico, Central America and the Caribbean, South America, Europe and Asia. Aeroméxico (Skyteam) is based at this airport, and provide codeshare agreements with non-Mexican airlines that span the entire globe. In 2014, the airport handled well over 34 million passengers, just over 2 million more than the year before. This traffic exceeds the current capacity of the airport, which has historically centralized the majority of air traffic in the country. An alternate option is Lic. Adolfo López Mateos International Airport (IATA Airport Code: TLC) in nearby Toluca, State of Mexico, although due to several airlines' decisions to terminate service to TLC, the airport has seen a passenger drop to just over 700,000 passengers in 2014 from over 2.1 million passengers just four years prior.
What is the short hand code for Mexico City's largest airport?
MEX

The Ottoman Empire began to collapse, and in 1908, the Young Turk Revolution overthrew the government of Sultan Hamid. In April 1909, the Adana massacre occurred in the Adana Vilayet of the Ottoman Empire resulting in the deaths of as many as 20,000–30,000 Armenians. The Armenians living in the empire hoped that the Committee of Union and Progress would change their second-class status. Armenian reform package (1914) was presented as a solution by appointing an inspector general over Armenian issues.
How many Armenians died in the Adana Massacre?
20,000–30,000

In the United States, new pharmaceutical products must be approved by the Food and Drug Administration (FDA) as being both safe and effective. This process generally involves submission of an Investigational New Drug filing with sufficient pre-clinical data to support proceeding with human trials. Following IND approval, three phases of progressively larger human clinical trials may be conducted. Phase I generally studies toxicity using healthy volunteers. Phase II can include pharmacokinetics and dosing in patients, and Phase III is a very large study of efficacy in the intended patient population. Following the successful completion of phase III testing, a New Drug Application is submitted to the FDA. The FDA review the data and if the product is seen as having a positive benefit-risk assessment, approval to market the product in the US is granted.
What type of risk assessment results in approving the drug to go on the market?
positive benefit-risk